MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming.

MLA

Liu, Yang, et al. “MiR-612 Regulates Invadopodia of Hepatocellular Carcinoma by HADHA-Mediated Lipid Reprogramming.” Journal of Hematology & Oncology, vol. 13, no. 1, Feb. 2020, p. 12. EBSCOhost, https://doi.org/10.1186/s13045-019-0841-3.

APA

Liu, Y., Lu, L.-L., Wen, D., Liu, D.-L., Dong, L.-L., Gao, D.-M., Bian, X.-Y., Zhou, J., Fan, J., & Wu, W.-Z. (2020). MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming. Journal of Hematology & Oncology, 13(1), 12. https://doi.org/10.1186/s13045-019-0841-3

Chicago

Liu, Yang, Li-Li Lu, Duo Wen, Dong-Li Liu, Li-Li Dong, Dong-Mei Gao, Xin-Yu Bian, Jian Zhou, Jia Fan, and Wei-Zhong Wu. 2020. “MiR-612 Regulates Invadopodia of Hepatocellular Carcinoma by HADHA-Mediated Lipid Reprogramming.” Journal of Hematology & Oncology 13 (1): 12. doi:10.1186/s13045-019-0841-3.